In this webinar, Drs. Rossi, Moore, and Schlesinger focus on current and emerging treatment approaches for actinic keratosis, with a focus on photodynamic therapy. The panel members also share take-home points related to treatment selection and patient care, as well as how they have adapted their practices during the COVID-19 pandemic.
This activity is supported by an unrestricted educational grant from Biofrontera.
Upon completion of this activity, the participant should be able to:
This educational activity is provided by Evolve Medical Education LLC (Evolve).
Accreditation Statement
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistant Continuing Education
PAs may claim a maximum of 0.5 Category 1 credits for completing this activity. National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Angela Yen Moore, MD
Arlington Center for Dermatology
Arlington Research Center
Arlington, TX
Anthony M. Rossi, MD, FAAD
Dermatologic, Mohs, & Laser Surgery
Assistant Professor
Weill Cornell Medical College
Assistant Attending
New York Presbyterian Hospital
Memorial Sloan Kettering Cancer Center
New York, NY
Todd Schlesinger, MD, FAAD
Director, Dermatology and Laser Center of Charleston
Clinical Research Center of the Carolinas Clinical Instructor
University at Buffalo Department of Dermatology Affiliate Assistant Professor
Medical University of South Carolina College of Medicine Clinical Preceptor
Medical University of South Carolina College of Health Professions Clinical Instructor
Edward Via College of Osteopathic Medicine
Charleston, SC
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Angela Yen Moore, MD, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Almirall, Biofrontera, Briston-Myers Squibb, and Mayne Pharma. Grant/Research Support: Abbvie, Almirall, Arcutis, Biofrontera, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, DS Biopharma, Eli Lilly, Galderma, Incyte, Janssen, Mayne Pharma, Novartis, Parexel, Pfizer, UCB, Verrica, and Vyne. Speakers Bureau: Abbvie, Almirall, Leo, Parexel, and Vyne. Advisory Board: EpiHealth, Evolus, Janssen, and Leo.
Anthony M. Rossi, MD, FAAD, has had a financial relationship or affiliation with the following ineligible companies in the form of Advisory Board: Allergan. Consultant: Almirall, Biofrontera, Canfield Scientific, Dynamed, Evolus, Lam Therapeutics, Merz, Quantia MD, and Regeneron Pharmaceuticals. Grant/Research Support: Biofrontera, Leo Pharma, and Regeneron Pharmaceuticals. Speaker’s Bureau: Almirall, and Biofrontera.
Todd Schlesinger, MD, FAAD, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Aclaris, Almirall, Allergan, BioPharmx, Bristol-Meyers Squibb, Castle BioScience, CMS Aesthetics DCME, Eli Lilly, EPI Health, Evolus, Galderma, Kintor, Leo Pharmaceuticals, Lilly, Merz, MJH Associates ONCLive SCC, Nextphase, Novartis, Ortho Dermatologics, Pfizer, Pharmatecture, Pierre Fabre, Plasmed, Prolacta Bioscience, Pulse Biosciences, Regeneron, Sisaf, Skinceuticals/L'Oreal, Sun Pharma, UCB, and Verrica. Grant/Research Support: AbbVie, Acrutis Premier Research, Akros, Allergan, Anterios, AOBiome, Arcutis Biotherapeutics, Astellas Pharma US, Inc, Athenex, Bioderma, Biofrontera, BioPharmx, Biorasi, Boehringer Ingerlheim, Brickell Biotech, Bristol-Meyers Squibb, Cara Therapeutics, Castle BioScience, Celgene, Centocor Ortho Biotech (Now Janssen Biotech), ChemoCentryx, Coherus Biosciences, Concert Pharmaceutical, Corrona, Cutanea Life Sciences, Dermavant, Dermira, DT Pharmacy & DT Collagen (Melasma), Eli Lilly, EPI Health, Galderma (Nestle), Genentech, Janssen Pharmaceuticals, Inc, Kinex, Kiniksa, Leo, Lilly, Merz, Nestle Skin Health, Nimbus, Novartis, Pfizer, Processa, Pulse BioSciences, Regeneron, Sanofi Genzyme, Sisaf, Tetra Derm Group, LLC and Trevi. Speakers Bureau: Aclaris, Almirall, Dermira, EPI Health, DUSA, MED Learning Group, Regeneron, Sanofi, and Sun Pharma. Advisory Board: Allergan, Almirall, Amgen, Bioderma, Biofrontera AG, Celgene, Greenway Therapeutix, and Remedly, Inc. Shareholder: Amben, Bristol-Myers Squibb, and Eli Lilly.
The Evolve staff and planners have no financial relationships with ineligible companies.
Neill T. Peters, MD, peer reviewer, has no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Biofrontera.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
